IPO Trending
BLUEJETEQ / NSE, BSEListed

Blue Jet Healthcare Limited

Incorporated in 1968, Blue Jet Healthcare is a science-led pharmaceutical company specializing in healthcare ingredients and intermediates. The company was the first in India to manufacture saccharin and its salts and has since expanded into contrast media intermediates for CT scans and MRIs. Its main product categories include contrast media intermediates, high-intensity sweeteners, and pharmaceutical intermediates and APIs. Blue Jet Healthcare offers process development, production capabilities, global regulatory support, and collaboration in advanced pharmaceutical development. The company operates three manufacturing facilities in Shahad, Ambernath, and Mahad, Maharashtra, with annual installed capacities of 200.60 KL, 607.30 KL, and 213.00 KL, respectively, as of June 30, 2023.

₹329 - ₹3467.94x sub
Listed Price380.00
Listing Gain+9.83%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Jun 2023)184.6 Cr
Growth-73.7%
Revenue Trend (₹ in Crores)
0.0285.6571.1856.7Mar 2022Mar 2023Jun 2023
PeriodRev (Cr)PAT (Cr)AssetsDebt
Jun 2023184.6044.12903.800
Mar 2023744.94160.03862.070
Mar 2022702.88181.59713.380
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values9.2326.60%31.91%37.4934.02